Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.09
+0.09 (1.80%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $298.78 million as of March 24, 2026. Its market cap has increased by 18.86% in one year.
Market Cap
298.78M
Enterprise Value
181.16M
1-Year Change
18.86%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $298.78M, a decrease of -47.16%. That is a compound annual growth rate of -11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 298.78M | -2.16% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 312.40M |
| Avalo Therapeutics | 307.64M |
| Crescent Biopharma | 303.91M |
| NovaBridge Biosciences | 303.22M |
| Bicycle Therapeutics | 302.53M |
| Neurogene | 299.88M |
| Immix Biopharma | 295.82M |
| Armata Pharmaceuticals | 293.91M |